NAS:QTNT (Switzerland)
Business Description
Quotient Ltd
NAICS : 325413
SIC : 3844
Description
Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | -0.87 | |||||
| Debt-to-Equity | -1.78 | |||||
| Debt-to-EBITDA | -2.93 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -7.34 | |||||
| Beneish M-Score | -2.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.7 | |||||
| 3-Year EBITDA Growth Rate | 14.6 | |||||
| 3-Year EPS without NRI Growth Rate | 14.1 | |||||
| 3-Year FCF Growth Rate | 6.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.03 | |||||
| 9-Day RSI | 43.87 | |||||
| 14-Day RSI | 42.19 | |||||
| 6-1 Month Momentum % | -84.97 | |||||
| 12-1 Month Momentum % | -94.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 337.13 | |||||
| Days Sales Outstanding | 51.4 | |||||
| Days Payable | 68.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.85 | |||||
| Operating Margin % | -281.74 | |||||
| Net Margin % | -357.5 | |||||
| ROA % | -61.94 | |||||
| ROIC % | -106.05 | |||||
| ROC (Joel Greenblatt) % | -140.83 | |||||
| ROCE % | -53.16 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.45 | |||||
| EV-to-EBIT | -2.42 | |||||
| EV-to-EBITDA | -2.58 | |||||
| EV-to-Revenue | 6.27 | |||||
| EV-to-FCF | -1.94 | |||||
| Earnings Yield (Greenblatt) % | -41.03 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QTNT
Peter Lynch Chart
Performance
Dividend
Annualized Return %
Total Annual Return %
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 38.239 | ||
| EPS (TTM) ($) | -1.34 | ||
| Beta | 3.47 | ||
| Volatility % | 75.68 | ||
| 14-Day RSI | 42.19 | ||
| 14-Day ATR ($) | 0.019565 | ||
| 20-Day SMA ($) | 0.174835 | ||
| 12-1 Month Momentum % | -94.68 | ||
| 52-Week Range ($) | 0.1418 - 3.185 | ||
| Shares Outstanding (Mil) | 135.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quotient Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quotient Ltd Analysis
Share your researchHeadlines
See More
No news.